Literature DB >> 30633985

Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.

Camila Dorotea Costa1, Andre Augusto Justo2, Priscila Emiko Kobayashi2, Michelle M Story3, Chiara Palmieri3, Renée Laufer Amorim2, Carlos Eduardo Fonseca-Alves4.   

Abstract

The cancer cell population is heterogeneous, and cancer stem cells (CSCs) are important for tumor growth and maintenance. The CSC population is associated with different neoplastic characteristics, such as cell migration, resistance to apoptosis, radiation therapy and chemotherapy. To increase the knowledge of CSCs in canine prostate cancer (PC), we characterized CSC markers in canine PC tissues and tumorspheres. We performed immunohistochemistry of OCT3/4, Nestin, NANOG, CD44 and CD24 in 10 normal canine prostatic tissue samples, 10 prostatic hyperplastic (PH) tissue samples and 28 PC tissue samples. Then, we established two canine prostate cancer cell cultures and characterized the CSC profile of tumorspheres grown from these cultures. Normal and PH tissues were positive for Nestin, NANOG, CD44 and CD24 only in the basal cell layer. OCT3/4 was expressed in the luminal cells of normal and PH tissues. There was no significant difference in Nestin expression among the prostatic tissues. However, we found higher expression of NANOG and CD44 in canine PC tissues than that in normal and PH tissues. Tumorspheres from canine prostate cancer cells express OCT3/4, Nestin, NANOG and CD44, indicating that these markers may be potential cancer stem cell markers in canine PC. The results obtained can be useful to better characterize the stem cell population in canine prostatic cancer and to guide future studies in comparative oncology.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD44; Dog; NANOG; OCT3/4; Prostate cancer

Mesh:

Substances:

Year:  2019        PMID: 30633985     DOI: 10.1016/j.biocel.2019.01.002

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

Review 1.  A Review on Canine and Feline Prostate Pathology.

Authors:  Chiara Palmieri; Carlos Eduardo Fonseca-Alves; Renee Laufer-Amorim
Journal:  Front Vet Sci       Date:  2022-05-26

2.  Expression of tumour transcription factor GLI1 in canine mammary tumours tissue.

Authors:  Penggang Liu; Yurong Lu; Yang Yang; Xueli Chen; Wenbing Xiong; Jing Sun
Journal:  Vet Med Sci       Date:  2022-06-06

3.  PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta†.

Authors:  Elisa T Zhang; Roberta L Hannibal; Keyla M Badillo Rivera; Janet H T Song; Kelly McGowan; Xiaowei Zhu; Gudrun Meinhardt; Martin Knöfler; Jürgen Pollheimer; Alexander E Urban; Ann K Folkins; Deirdre J Lyell; Julie C Baker
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

4.  E-Cadherin Downregulation is Mediated by Promoter Methylation in Canine Prostate Cancer.

Authors:  Carlos Eduardo Fonseca-Alves; Priscila Emiko Kobayashi; Antonio Fernando Leis-Filho; Patricia de Faria Lainetti; Valeria Grieco; Hellen Kuasne; Silvia Regina Rogatto; Renee Laufer-Amorim
Journal:  Front Genet       Date:  2019-11-29       Impact factor: 4.599

5.  Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.

Authors:  Maria Carolina Mangini Prado; Sofia de Almeida Losant Macedo; Giulia Gumiero Guiraldelli; Patricia de Faria Lainetti; Antonio Fernando Leis-Filho; Priscila Emiko Kobayashi; Renee Laufer-Amorim; Carlos Eduardo Fonseca-Alves
Journal:  Front Oncol       Date:  2019-12-19       Impact factor: 6.244

6.  Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.

Authors:  Federica Iannelli; Maria Serena Roca; Rita Lombardi; Chiara Ciardiello; Laura Grumetti; Simona De Rienzo; Tania Moccia; Carlo Vitagliano; Angela Sorice; Susan Costantini; Maria Rita Milone; Biagio Pucci; Alessandra Leone; Elena Di Gennaro; Rita Mancini; Gennaro Ciliberto; Francesca Bruzzese; Alfredo Budillon
Journal:  J Exp Clin Cancer Res       Date:  2020-10-08

7.  Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway.

Authors:  Priscila E Kobayashi; Patrícia F Lainetti; Antonio F Leis-Filho; Flávia K Delella; Marcio Carvalho; Sarah Santiloni Cury; Robson Francisco Carvalho; Carlos E Fonseca-Alves; Renée Laufer-Amorim
Journal:  Front Vet Sci       Date:  2020-11-26

8.  Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis.

Authors:  Xinyi Zhang; Changsheng Xing; Wenting Guan; Lang Chen; Kai Guo; Anze Yu; Kai Xie
Journal:  Cancer Cell Int       Date:  2020-05-14       Impact factor: 5.722

Review 9.  The key roles of cancer stem cell-derived extracellular vesicles.

Authors:  Chaoyue Su; Jianye Zhang; Yosef Yarden; Liwu Fu
Journal:  Signal Transduct Target Ther       Date:  2021-03-08

10.  Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo.

Authors:  Patrícia de Faria Lainetti; Andressa Brandi; Antonio Fernando Leis Filho; Maria Carolina Mangini Prado; Priscila Emiko Kobayashi; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves
Journal:  Front Vet Sci       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.